Rheumatoid arthritis

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis

RMD OpenPublished Prospective cohort study

Authors' conclusion

Our data support the potential value of remote PRO monitoring of RA patients in drug-free remission to identify flare occurrence.

Study context

Population
Rheumatoid arthritis (RA) patients in sustained remission after conventional synthetic disease-modifying antirheumatic drug (csDMARD) cessation (BIO-FLARE cohort)70.1% females
Participants
121 patients
Exposure
Changes in four PROs as predictors of flare after csDMARD cessation
Outcome
Flare (DAS28-CRP ≥3.2 at any visit, DAS28-CRP ≥2.4 on two visits within 2 weeks, or resuming DMARD and/or steroid therapy despite DAS28-CRP <2.4)
Follow-up
6-month follow-up
Methodological detailsCox regression with time-varying covariates, ROC curve analysis
  • Cox regression with time-varying covariates
  • ROC curve analysis

Main finding

As reported in the abstract

Flare detection by PRO change
GroupAUCPPV (increment ≥5.5 from baseline)NPV (increment ≥5.5 from baseline)
FLARE-RA0.90 (95% CI 0.84 to 0.96; p=0.001)— not stated in the abstract— not stated in the abstract
RA Flare Questionnaire (RA-FQ)0.90 (95% CI 0.84 to 0.96; p=0.001)80%91%

AUC

FLARE-RA0.90 (95% CI 0.84 to 0.96; p=0.001)
RA Flare Questionnaire (RA-FQ)0.90 (95% CI 0.84 to 0.96; p=0.001)

PPV (increment ≥5.5 from baseline)

FLARE-RA— not stated in the abstract
RA Flare Questionnaire (RA-FQ)80%

NPV (increment ≥5.5 from baseline)

FLARE-RA— not stated in the abstract
RA Flare Questionnaire (RA-FQ)91%

— not stated in the abstract

Flare occurred
58/121 (47.9%)
1-point change in each PRO score strongly associated with flare (multivariate Cox regression)
P < 0.001 in each case

Observational data: associations, not effects.

Original publication

Patient-reported outcomes as early warning signs of flare following drug cessation in rheumatoid arthritis. RMD Open. Published 1 April 2025. doi:10.1136/rmdopen-2025-005442

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.